07-758
抗磷-Flt-1 (Tyr1213)抗体
Upstate®, from rabbit
别名:
Vascular endothelial growth factor receptor 1 (VEGFR-1), Vascular permeability factor receptor, Tyrosine-protein kinase FRT, Fms-like tyrosine kinase
产品名称
抗磷-Flt-1 (Tyr1213)抗体, Upstate®, from rabbit
biological source
rabbit
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
bovine, human, goat, sheep, rat, mouse
manufacturer/tradename
Upstate®
technique(s)
western blot: suitable
isotype
IgG
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pTyr1213)
Quality Level
Gene Information
bovine ... Flt1(503620)
human ... FLT1(2321)
mouse ... Flt1(14254)
rat ... Flt1(54251)
Preparation Note
自收到之日起，在2-8°C条件下可稳定保存1年。 避免反复冻融循环，以免损坏IgG和影响产品性能。
Analysis Note
对照
重组Flt-1（目录号14-562）被ATP磷酸化
重组Flt-1（目录号14-562）被ATP磷酸化
通过免疫印迹法对ATP孵育后磷酸化的重组Flt-1（目录号14-562）进行常规评估
Application
抗磷酸-Flt-1 (Tyr1213)抗体可检测磷酸-Flt-1 (Tyr1213)水平 & 已发布 & 经验证可用于WB。
研究子范畴
生长因子 & 受体
生长因子 & 受体
研究类别
信号传导
信号传导
Biochem/physiol Actions
识别磷酸-Flt-1 (Tyr1213)。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
~180 kDa（QC检测片段为66 kDa）
Immunogen
KLH缀合的合成肽，包含序列(...VR[pY]VN...)，其中[pY]对应于人Flt-1残基1213处的磷酸酪氨酸。免疫序列在狨猴中相同，在大鼠、山羊、绵羊、奶牛和恒河猴中有14/15个相同氨基酸，在小鼠中有13/15个相同氨基酸。
Other Notes
浓度：请参考批次特异性浓缩物的检验报告。
Physical form
免疫亲和性纯化兔IgG ，溶于0.1 Tris-甘氨酸（pH 7.4）、0.15 NaCl和0.05％叠氮化钠中。
免疫亲和纯化
Legal Information
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
Marga van de Vegte-Bolmer et al.
Malaria journal, 20(1), 381-381 (2021-09-28)
The ability to culture Plasmodium falciparum continuously in vitro has enabled stable access to asexual and sexual parasites for malaria research. The portfolio of isolates has remained limited and research is still largely based on NF54 and its derived clone
Paul Mésange et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 24(11), 2548-2558 (2018-03-02)
Purpose: There is extensive cross-talk between VEGF- and EGFR-pathway signaling in colorectal cancer. However, combinations of VEGF- and EGFR-targeted monoclonal antibodies (mAb) show disappointing activity, in particular for patients with mutant RAS Previous results show that tyrosine kinase inhibitors (TKI)
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies.
Poindessous, V; Ouaret, D; El Ouadrani, K; Battistella, A; Megalophonos, VF; Kamsu-Kom et al.
Clinical cancer research : an official journal of the American Association for Cancer Research null
Weihua Guan et al.
PloS one, 6(9), e24551-e24551 (2011-09-14)
We identified that the angiotensin receptor antagonist, candesartan, has profound neurovascular protective properties when administered after ischemic stroke and was associated with a proangiogenic state at least partly explained by vascular endothelial growth factor A (VEGFA). However, the spatial distribution
Chuanke Zhao et al.
Cancer science, 106(11), 1596-1606 (2015-08-25)
Angiogenesis is a prerequisite of tumor growth and metastasis and, thus, anti-angiogenesis treatment has become an important part of cancer therapy. A 15-amino acid peptide of the fibrinogen α chain, fibrinostatin, was previously found in serum samples of gastric cancer
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持